Onesource Specialty Pharma: Addendum to 19th AGM Notice

Onesource Specialty Pharma Ltd has issued an addendum to the notice of its 19th Annual General Meeting (AGM), scheduled for September 23, 2026. This addendum forms an integral part of the original notice dated July 24, 2026. It provides additional disclosures related to Item No. 6 & 7 of the AGM notice, specifically concerning material related party transactions (RPTs) with Strides Pharma Science Limited and its wholly-owned subsidiary, Strides Pharma Inc., USA. The addendum confirms that the Audit Committee has reviewed the necessary certificates from the CEO/CFO as per RPT industry standards. The updated information is available on the company's website and the stock exchanges.